Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network
Summary What is known and objective The literature has reported suboptimal real‐world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharma...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical pharmacy and therapeutics 2018-12, Vol.43 (6), p.877-887 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 887 |
|---|---|
| container_issue | 6 |
| container_start_page | 877 |
| container_title | Journal of clinical pharmacy and therapeutics |
| container_volume | 43 |
| creator | Chartrand, Mylène Lalonde, Lyne Cantin, Ariane Lahaie, Alexandre Odobasic, Bojan Tremblay, Marie‐Philip Wazzan, Dana Gagnon, Marie‐Mireille Martin, Élisabeth Dorais, Marc Berbiche, Djamal Guénette, Line |
| description | Summary
What is known and objective
The literature has reported suboptimal real‐world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharmacists to evaluate and improve their clinical practices. Our objective was to assess the feasibility of implementing, through a practice‐based research network (PBRN), a quality improvement programme on AMSs by community pharmacists for AF patients and explore its impact on the quality of clinical practices and pharmacists’ knowledge.
Methods
An uncontrolled pre/post‐pilot study was conducted through a PBRN. Pharmacists identified 5‐20 AF patients on oral anticoagulants per pharmacy and completed questionnaires at baseline (T0) and after 6 months (T6). Clinical practices were evaluated using a set of quality indicators (QIs). QI scores ranged from 0% (no QI achieved) to 100% (all QIs achieved). The programme included an audit and feedback based on QIs and a personalized training programme (including online videos). Participation rates and satisfaction were documented. Mean changes (T6‐T0), with 95% confidence interval (CI), in QIs and knowledge scores were computed.
Results and discussion
A total of 37 pharmacies (50 pharmacists) identified 222 patients who had received either vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), or both. All pharmacies received their baseline quality report (audit), and facilitators contacted by phone 97% of pharmacies (feedback). Each of the six online videos was completed by at least 48% of pharmacists. Baseline mean global QI scores for VKAs and DOACs were 39.1% (95% CI: 35.7%‐42.4%) and 12.3% (7.8%‐16.8%), respectively. Over a 6‐month period, they increased by 12.5% points (7.5%‐17.5%) and 9.9% points (3.8%‐16.1%), respectively. Baseline mean global knowledge score was 68.7% (65.4%‐72.0%) and increased by 4.3% points (1.2%‐7.4%).
What is new and conclusion
Implementing a quality improvement programme for AMS in community pharmacy is relevant and feasible and may improve pharmacists’ practices and knowledge.
Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated. This study assessed the feasibility of implementing, through a practice‐based research network, a quality improvement programme on AMSs for atrial fibrillation patients. Results show the programme is relevant and fea |
| doi_str_mv | 10.1111/jcpt.12745 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2071583813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2071583813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3935-1df57dbfe7cefdcd1bc84fd1ab029c4a1eeacdaf366a6440c76d1c718098422e3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0EotPChgdAltigSim-JHHCrhpRLqoEi7KOTpyTjIfYntpJq9nxCDwDj8aT4JkUFizwxtY5nz_90k_IC84ueDpvtno3XXCh8uIRWXFZFplQnD0mKybKOsuVUCfkNMYtY6xUQj4lJ5IxXsucr8jPSzcZ7WGYR5iMd9SCgwEtuolGDHdGY6TGUe2tnZ2Z9nS3gWBB79_SK4RoWjMepr6nxu7G40fjBgr0dobjJo2Dv1uM6TUEsBbptAl-HjaJ2wXQKQL--v6jhYgdDRgRgt5Qh9O9D9-ekSc9jBGfP9xn5OvVu5v1h-z68_uP68vrTMtaFhnv-kJ1bY9KY9_pjre6yvuOQ8tErXPgiKA76GVZQpnnTKuy41rxitVVLgTKM_J68aaUtzPGqbEmahxHcOjn2AimeFHJisuEvvoH3fo5uJSuEVwURVHnnCfqfKF08DEG7JtdMBbCvuGsOTTXHJprjs0l-OWDcm4tdn_RP1UlgC_AvRlx_x9V82n95WaR_gZGK6ok</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2125559411</pqid></control><display><type>article</type><title>Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chartrand, Mylène ; Lalonde, Lyne ; Cantin, Ariane ; Lahaie, Alexandre ; Odobasic, Bojan ; Tremblay, Marie‐Philip ; Wazzan, Dana ; Gagnon, Marie‐Mireille ; Martin, Élisabeth ; Dorais, Marc ; Berbiche, Djamal ; Guénette, Line</creator><creatorcontrib>Chartrand, Mylène ; Lalonde, Lyne ; Cantin, Ariane ; Lahaie, Alexandre ; Odobasic, Bojan ; Tremblay, Marie‐Philip ; Wazzan, Dana ; Gagnon, Marie‐Mireille ; Martin, Élisabeth ; Dorais, Marc ; Berbiche, Djamal ; Guénette, Line</creatorcontrib><description>Summary
What is known and objective
The literature has reported suboptimal real‐world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharmacists to evaluate and improve their clinical practices. Our objective was to assess the feasibility of implementing, through a practice‐based research network (PBRN), a quality improvement programme on AMSs by community pharmacists for AF patients and explore its impact on the quality of clinical practices and pharmacists’ knowledge.
Methods
An uncontrolled pre/post‐pilot study was conducted through a PBRN. Pharmacists identified 5‐20 AF patients on oral anticoagulants per pharmacy and completed questionnaires at baseline (T0) and after 6 months (T6). Clinical practices were evaluated using a set of quality indicators (QIs). QI scores ranged from 0% (no QI achieved) to 100% (all QIs achieved). The programme included an audit and feedback based on QIs and a personalized training programme (including online videos). Participation rates and satisfaction were documented. Mean changes (T6‐T0), with 95% confidence interval (CI), in QIs and knowledge scores were computed.
Results and discussion
A total of 37 pharmacies (50 pharmacists) identified 222 patients who had received either vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), or both. All pharmacies received their baseline quality report (audit), and facilitators contacted by phone 97% of pharmacies (feedback). Each of the six online videos was completed by at least 48% of pharmacists. Baseline mean global QI scores for VKAs and DOACs were 39.1% (95% CI: 35.7%‐42.4%) and 12.3% (7.8%‐16.8%), respectively. Over a 6‐month period, they increased by 12.5% points (7.5%‐17.5%) and 9.9% points (3.8%‐16.1%), respectively. Baseline mean global knowledge score was 68.7% (65.4%‐72.0%) and increased by 4.3% points (1.2%‐7.4%).
What is new and conclusion
Implementing a quality improvement programme for AMS in community pharmacy is relevant and feasible and may improve pharmacists’ practices and knowledge.
Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated. This study assessed the feasibility of implementing, through a practice‐based research network, a quality improvement programme on AMSs for atrial fibrillation patients. Results show the programme is relevant and feasible and may improve pharmacists’ practices and knowledge.</description><identifier>ISSN: 0269-4727</identifier><identifier>EISSN: 1365-2710</identifier><identifier>DOI: 10.1111/jcpt.12745</identifier><identifier>PMID: 30019341</identifier><language>eng</language><publisher>England: Hindawi Limited</publisher><subject>Aged ; Aged, 80 and over ; Antagonists ; Anticoagulants ; Anticoagulants - administration & dosage ; anticoagulation management services ; Attitude of Health Personnel ; community pharmacy ; Community Pharmacy Services - organization & administration ; Community Pharmacy Services - standards ; Drug stores ; Feasibility Studies ; Feedback ; Female ; Fibrillation ; Health Knowledge, Attitudes, Practice ; Humans ; Internet ; Male ; Management services ; Pharmacists ; Pharmacists - organization & administration ; Pharmacists - standards ; Pilot Projects ; Practice research ; practice‐based research network ; Professional Role ; Quality ; Quality control ; Quality Improvement ; quality improvement programme ; quality indicators ; Quality Indicators, Health Care ; Vitamin K</subject><ispartof>Journal of clinical pharmacy and therapeutics, 2018-12, Vol.43 (6), p.877-887</ispartof><rights>2018 John Wiley & Sons Ltd</rights><rights>2018 John Wiley & Sons Ltd.</rights><rights>Copyright © 2018 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3935-1df57dbfe7cefdcd1bc84fd1ab029c4a1eeacdaf366a6440c76d1c718098422e3</citedby><cites>FETCH-LOGICAL-c3935-1df57dbfe7cefdcd1bc84fd1ab029c4a1eeacdaf366a6440c76d1c718098422e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjcpt.12745$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjcpt.12745$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30019341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chartrand, Mylène</creatorcontrib><creatorcontrib>Lalonde, Lyne</creatorcontrib><creatorcontrib>Cantin, Ariane</creatorcontrib><creatorcontrib>Lahaie, Alexandre</creatorcontrib><creatorcontrib>Odobasic, Bojan</creatorcontrib><creatorcontrib>Tremblay, Marie‐Philip</creatorcontrib><creatorcontrib>Wazzan, Dana</creatorcontrib><creatorcontrib>Gagnon, Marie‐Mireille</creatorcontrib><creatorcontrib>Martin, Élisabeth</creatorcontrib><creatorcontrib>Dorais, Marc</creatorcontrib><creatorcontrib>Berbiche, Djamal</creatorcontrib><creatorcontrib>Guénette, Line</creatorcontrib><title>Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network</title><title>Journal of clinical pharmacy and therapeutics</title><addtitle>J Clin Pharm Ther</addtitle><description>Summary
What is known and objective
The literature has reported suboptimal real‐world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharmacists to evaluate and improve their clinical practices. Our objective was to assess the feasibility of implementing, through a practice‐based research network (PBRN), a quality improvement programme on AMSs by community pharmacists for AF patients and explore its impact on the quality of clinical practices and pharmacists’ knowledge.
Methods
An uncontrolled pre/post‐pilot study was conducted through a PBRN. Pharmacists identified 5‐20 AF patients on oral anticoagulants per pharmacy and completed questionnaires at baseline (T0) and after 6 months (T6). Clinical practices were evaluated using a set of quality indicators (QIs). QI scores ranged from 0% (no QI achieved) to 100% (all QIs achieved). The programme included an audit and feedback based on QIs and a personalized training programme (including online videos). Participation rates and satisfaction were documented. Mean changes (T6‐T0), with 95% confidence interval (CI), in QIs and knowledge scores were computed.
Results and discussion
A total of 37 pharmacies (50 pharmacists) identified 222 patients who had received either vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), or both. All pharmacies received their baseline quality report (audit), and facilitators contacted by phone 97% of pharmacies (feedback). Each of the six online videos was completed by at least 48% of pharmacists. Baseline mean global QI scores for VKAs and DOACs were 39.1% (95% CI: 35.7%‐42.4%) and 12.3% (7.8%‐16.8%), respectively. Over a 6‐month period, they increased by 12.5% points (7.5%‐17.5%) and 9.9% points (3.8%‐16.1%), respectively. Baseline mean global knowledge score was 68.7% (65.4%‐72.0%) and increased by 4.3% points (1.2%‐7.4%).
What is new and conclusion
Implementing a quality improvement programme for AMS in community pharmacy is relevant and feasible and may improve pharmacists’ practices and knowledge.
Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated. This study assessed the feasibility of implementing, through a practice‐based research network, a quality improvement programme on AMSs for atrial fibrillation patients. Results show the programme is relevant and feasible and may improve pharmacists’ practices and knowledge.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antagonists</subject><subject>Anticoagulants</subject><subject>Anticoagulants - administration & dosage</subject><subject>anticoagulation management services</subject><subject>Attitude of Health Personnel</subject><subject>community pharmacy</subject><subject>Community Pharmacy Services - organization & administration</subject><subject>Community Pharmacy Services - standards</subject><subject>Drug stores</subject><subject>Feasibility Studies</subject><subject>Feedback</subject><subject>Female</subject><subject>Fibrillation</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Internet</subject><subject>Male</subject><subject>Management services</subject><subject>Pharmacists</subject><subject>Pharmacists - organization & administration</subject><subject>Pharmacists - standards</subject><subject>Pilot Projects</subject><subject>Practice research</subject><subject>practice‐based research network</subject><subject>Professional Role</subject><subject>Quality</subject><subject>Quality control</subject><subject>Quality Improvement</subject><subject>quality improvement programme</subject><subject>quality indicators</subject><subject>Quality Indicators, Health Care</subject><subject>Vitamin K</subject><issn>0269-4727</issn><issn>1365-2710</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhi0EotPChgdAltigSim-JHHCrhpRLqoEi7KOTpyTjIfYntpJq9nxCDwDj8aT4JkUFizwxtY5nz_90k_IC84ueDpvtno3XXCh8uIRWXFZFplQnD0mKybKOsuVUCfkNMYtY6xUQj4lJ5IxXsucr8jPSzcZ7WGYR5iMd9SCgwEtuolGDHdGY6TGUe2tnZ2Z9nS3gWBB79_SK4RoWjMepr6nxu7G40fjBgr0dobjJo2Dv1uM6TUEsBbptAl-HjaJ2wXQKQL--v6jhYgdDRgRgt5Qh9O9D9-ekSc9jBGfP9xn5OvVu5v1h-z68_uP68vrTMtaFhnv-kJ1bY9KY9_pjre6yvuOQ8tErXPgiKA76GVZQpnnTKuy41rxitVVLgTKM_J68aaUtzPGqbEmahxHcOjn2AimeFHJisuEvvoH3fo5uJSuEVwURVHnnCfqfKF08DEG7JtdMBbCvuGsOTTXHJprjs0l-OWDcm4tdn_RP1UlgC_AvRlx_x9V82n95WaR_gZGK6ok</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Chartrand, Mylène</creator><creator>Lalonde, Lyne</creator><creator>Cantin, Ariane</creator><creator>Lahaie, Alexandre</creator><creator>Odobasic, Bojan</creator><creator>Tremblay, Marie‐Philip</creator><creator>Wazzan, Dana</creator><creator>Gagnon, Marie‐Mireille</creator><creator>Martin, Élisabeth</creator><creator>Dorais, Marc</creator><creator>Berbiche, Djamal</creator><creator>Guénette, Line</creator><general>Hindawi Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network</title><author>Chartrand, Mylène ; Lalonde, Lyne ; Cantin, Ariane ; Lahaie, Alexandre ; Odobasic, Bojan ; Tremblay, Marie‐Philip ; Wazzan, Dana ; Gagnon, Marie‐Mireille ; Martin, Élisabeth ; Dorais, Marc ; Berbiche, Djamal ; Guénette, Line</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3935-1df57dbfe7cefdcd1bc84fd1ab029c4a1eeacdaf366a6440c76d1c718098422e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antagonists</topic><topic>Anticoagulants</topic><topic>Anticoagulants - administration & dosage</topic><topic>anticoagulation management services</topic><topic>Attitude of Health Personnel</topic><topic>community pharmacy</topic><topic>Community Pharmacy Services - organization & administration</topic><topic>Community Pharmacy Services - standards</topic><topic>Drug stores</topic><topic>Feasibility Studies</topic><topic>Feedback</topic><topic>Female</topic><topic>Fibrillation</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Internet</topic><topic>Male</topic><topic>Management services</topic><topic>Pharmacists</topic><topic>Pharmacists - organization & administration</topic><topic>Pharmacists - standards</topic><topic>Pilot Projects</topic><topic>Practice research</topic><topic>practice‐based research network</topic><topic>Professional Role</topic><topic>Quality</topic><topic>Quality control</topic><topic>Quality Improvement</topic><topic>quality improvement programme</topic><topic>quality indicators</topic><topic>Quality Indicators, Health Care</topic><topic>Vitamin K</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chartrand, Mylène</creatorcontrib><creatorcontrib>Lalonde, Lyne</creatorcontrib><creatorcontrib>Cantin, Ariane</creatorcontrib><creatorcontrib>Lahaie, Alexandre</creatorcontrib><creatorcontrib>Odobasic, Bojan</creatorcontrib><creatorcontrib>Tremblay, Marie‐Philip</creatorcontrib><creatorcontrib>Wazzan, Dana</creatorcontrib><creatorcontrib>Gagnon, Marie‐Mireille</creatorcontrib><creatorcontrib>Martin, Élisabeth</creatorcontrib><creatorcontrib>Dorais, Marc</creatorcontrib><creatorcontrib>Berbiche, Djamal</creatorcontrib><creatorcontrib>Guénette, Line</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacy and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chartrand, Mylène</au><au>Lalonde, Lyne</au><au>Cantin, Ariane</au><au>Lahaie, Alexandre</au><au>Odobasic, Bojan</au><au>Tremblay, Marie‐Philip</au><au>Wazzan, Dana</au><au>Gagnon, Marie‐Mireille</au><au>Martin, Élisabeth</au><au>Dorais, Marc</au><au>Berbiche, Djamal</au><au>Guénette, Line</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network</atitle><jtitle>Journal of clinical pharmacy and therapeutics</jtitle><addtitle>J Clin Pharm Ther</addtitle><date>2018-12</date><risdate>2018</risdate><volume>43</volume><issue>6</issue><spage>877</spage><epage>887</epage><pages>877-887</pages><issn>0269-4727</issn><eissn>1365-2710</eissn><abstract>Summary
What is known and objective
The literature has reported suboptimal real‐world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharmacists to evaluate and improve their clinical practices. Our objective was to assess the feasibility of implementing, through a practice‐based research network (PBRN), a quality improvement programme on AMSs by community pharmacists for AF patients and explore its impact on the quality of clinical practices and pharmacists’ knowledge.
Methods
An uncontrolled pre/post‐pilot study was conducted through a PBRN. Pharmacists identified 5‐20 AF patients on oral anticoagulants per pharmacy and completed questionnaires at baseline (T0) and after 6 months (T6). Clinical practices were evaluated using a set of quality indicators (QIs). QI scores ranged from 0% (no QI achieved) to 100% (all QIs achieved). The programme included an audit and feedback based on QIs and a personalized training programme (including online videos). Participation rates and satisfaction were documented. Mean changes (T6‐T0), with 95% confidence interval (CI), in QIs and knowledge scores were computed.
Results and discussion
A total of 37 pharmacies (50 pharmacists) identified 222 patients who had received either vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), or both. All pharmacies received their baseline quality report (audit), and facilitators contacted by phone 97% of pharmacies (feedback). Each of the six online videos was completed by at least 48% of pharmacists. Baseline mean global QI scores for VKAs and DOACs were 39.1% (95% CI: 35.7%‐42.4%) and 12.3% (7.8%‐16.8%), respectively. Over a 6‐month period, they increased by 12.5% points (7.5%‐17.5%) and 9.9% points (3.8%‐16.1%), respectively. Baseline mean global knowledge score was 68.7% (65.4%‐72.0%) and increased by 4.3% points (1.2%‐7.4%).
What is new and conclusion
Implementing a quality improvement programme for AMS in community pharmacy is relevant and feasible and may improve pharmacists’ practices and knowledge.
Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated. This study assessed the feasibility of implementing, through a practice‐based research network, a quality improvement programme on AMSs for atrial fibrillation patients. Results show the programme is relevant and feasible and may improve pharmacists’ practices and knowledge.</abstract><cop>England</cop><pub>Hindawi Limited</pub><pmid>30019341</pmid><doi>10.1111/jcpt.12745</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-4727 |
| ispartof | Journal of clinical pharmacy and therapeutics, 2018-12, Vol.43 (6), p.877-887 |
| issn | 0269-4727 1365-2710 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2071583813 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Aged, 80 and over Antagonists Anticoagulants Anticoagulants - administration & dosage anticoagulation management services Attitude of Health Personnel community pharmacy Community Pharmacy Services - organization & administration Community Pharmacy Services - standards Drug stores Feasibility Studies Feedback Female Fibrillation Health Knowledge, Attitudes, Practice Humans Internet Male Management services Pharmacists Pharmacists - organization & administration Pharmacists - standards Pilot Projects Practice research practice‐based research network Professional Role Quality Quality control Quality Improvement quality improvement programme quality indicators Quality Indicators, Health Care Vitamin K |
| title | Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice‐based research network |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T11%3A19%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticoagulation%20management%20services%20in%20community%20pharmacy:%20Feasibility%20of%20implementing%20a%20quality%20improvement%20programme%20through%20a%20practice%E2%80%90based%20research%20network&rft.jtitle=Journal%20of%20clinical%20pharmacy%20and%20therapeutics&rft.au=Chartrand,%20Myl%C3%A8ne&rft.date=2018-12&rft.volume=43&rft.issue=6&rft.spage=877&rft.epage=887&rft.pages=877-887&rft.issn=0269-4727&rft.eissn=1365-2710&rft_id=info:doi/10.1111/jcpt.12745&rft_dat=%3Cproquest_cross%3E2071583813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2125559411&rft_id=info:pmid/30019341&rfr_iscdi=true |